1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide

C125H155FN32O21S6 — CID 158903291

About 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide

1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide (PubChem CID 158903291) has the molecular formula C125H155FN32O21S6 and a molecular weight of 2653.22 g/mol. Its IUPAC name is 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide.

Molecular Properties

• Compound Name: 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide
• PubChem CID: 158903291
• Molecular Formula: C125H155FN32O21S6
• Molecular Weight: 2653.22 g/mol
• Exact Mass: 2651.04
• IUPAC Name: 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide
• SMILES: CC1CCc2cc3c(c(NC(=O)N=S(N)(=O)c4cnn5c4OCC(C)(C)C5)c21)CCC3.CC1CCc2cc3c(c(NC(=O)N=S(N)(=O)c4cnn5c4OCCC5)c21)CCC3.CNC1CCn2ncc(S(N)(=O)=NC(=O)Nc3c4c(cc5c3CCC5)CCC4)c2OC1.COC1COc2c(S(=O)(=NC(=O)Nc3c4c(cc5c3CCC5)CCC4)NC(C)=O)cnn2C1.COc1cc(-c2cc(F)cc(C(C)C)c2NC(=O)N=S(N)(=O)c2cnn3c2OCCC3)ccn1.NS(=O)(=NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1cnn2c1OCC2
• InChI: InChI=1S/C22H25FN6O4S.C22H27N5O5S.C22H29N5O3S.C21H28N6O3S.C20H25N5O3S.C18H21N5O3S/c1-13(2)16-10-15(23)11-17(14-5-6-25-19(9-14)32-3)20(16)27-22(30)28-34(24,31)18-12-26-29-7-4-8-33-21(18)29;1-13(28)25-33(30,19-10-23-27-11-16(31-2)12-32-21(19)27)26-22(29)24-20-17-7-3-5-14(17)9-15-6-4-8-18(15)20;1-13-7-8-15-9-14-5-4-6-16(14)19(18(13)15)25-21(28)26-31(23,29)17-10-24-27-11-22(2,3)12-30-20(17)27;1-23-15-8-9-27-20(30-12-15)18(11-24-27)31(22,29)26-21(28)25-19-16-6-2-4-13(16)10-14-5-3-7-17(14)19;1-12-6-7-14-10-13-4-2-5-15(13)18(17(12)14)23-20(26)24-29(21,27)16-11-22-25-8-3-9-28-19(16)25;19-27(25,15-10-20-23-7-8-26-17(15)23)22-18(24)21-16-13-5-1-3-11(13)9-12-4-2-6-14(12)16/h5-6,9-13H,4,7-8H2,1-3H3,(H3,24,27,28,30,31);9-10,16H,3-8,11-12H2,1-2H3,(H2,24,25,26,28,29,30);9-10,13H,4-8,11-12H2,1-3H3,(H3,23,25,26,28,29);10-11,15,23H,2-9,12H2,1H3,(H3,22,25,26,28,29);10-12H,2-9H2,1H3,(H3,21,23,24,26,27);9-10H,1-8H2,(H3,19,21,22,24,25)
• InChIKey: JFSIOSBKTVNMCI-UHFFFAOYSA-N
• XLogP: 17.57
• TPSA: 716.06 Ų
• H-Bond Donors: 13
• H-Bond Acceptors: 35
• Rotatable Bonds: 18
• Heavy Atoms: 185
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2653.22
LogP ≤ 5	17.57
H-Bond Donors ≤ 5	13
H-Bond Acceptors ≤ 10	35

Frequently Asked Questions

What is the IUPAC name of 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide?

The IUPAC name of 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide (CID 158903291) is 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide.

What is the SMILES notation for 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide?

The canonical SMILES for 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide is CC1CCc2cc3c(c(NC(=O)N=S(N)(=O)c4cnn5c4OCC(C)(C)C5)c21)CCC3.CC1CCc2cc3c(c(NC(=O)N=S(N)(=O)c4cnn5c4OCCC5)c21)CCC3.CNC1CCn2ncc(S(N)(=O)=NC(=O)Nc3c4c(cc5c3CCC5)CCC4)c2OC1.COC1COc2c(S(=O)(=NC(=O)Nc3c4c(cc5c3CCC5)CCC4)NC(C)=O)cnn2C1.COc1cc(-c2cc(F)cc(C(C)C)c2NC(=O)N=S(N)(=O)c2cnn3c2OCCC3)ccn1.NS(=O)(=NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1cnn2c1OCC2.

What is the InChIKey of 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide?

The InChIKey is JFSIOSBKTVNMCI-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25FN6O4S.C22H27N5O5S.C22H29N5O3S.C21H28N6O3S.C20H25N5O3S.C18H21N5O3S/c1-13(2)16-10-15(23)11-17(14-5-6-25-19(9-14)32-3)20(16)27-22(30)28-34(24,31)18-12-26-29-7-4-8-33-21(18)29;1-13(28)25-33(30,19-10-23-27-11-16(31-2)12-32-21(19)27)26-22(29)24-20-17-7-3-5-14(17)9-15-6-4-8-18(15)20;1-13-7-8-15-9-14-5-4-6-16(14)19(18(13)15)25-21(28)26-31(23,29)17-10-24-27-11-22(2,3)12-30-20(17)27;1-23-15-8-9-27-20(30-12-15)18(11-24-27)31(22,29)26-21(28)25-19-16-6-2-4-13(16)10-14-5-3-7-17(14)19;1-12-6-7-14-10-13-4-2-5-15(13)18(17(12)14)23-20(26)24-29(21,27)16-11-22-25-8-3-9-28-19(16)25;19-27(25,15-10-20-23-7-8-26-17(15)23)22-18(24)21-16-13-5-1-3-11(13)9-12-4-2-6-14(12)16/h5-6,9-13H,4,7-8H2,1-3H3,(H3,24,27,28,30,31);9-10,16H,3-8,11-12H2,1-2H3,(H2,24,25,26,28,29,30);9-10,13H,4-8,11-12H2,1-3H3,(H3,23,25,26,28,29);10-11,15,23H,2-9,12H2,1H3,(H3,22,25,26,28,29);10-12H,2-9H2,1H3,(H3,21,23,24,26,27);9-10H,1-8H2,(H3,19,21,22,24,25).

What are the key properties of 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide?

1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide has a molecular weight of 2653.22 g/mol, XLogP of 17.57, 18 rotatable bonds, 13 hydrogen bond donors, and 35 hydrogen bond acceptors.

Where does this data come from?

All data for 1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-[4-fluoro-2-(2-methoxy-4-pyridinyl)-6-propan-2-ylphenyl]urea;1-[amino-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(2,3-dihydropyrazolo[5,1-b][1,3]oxazol-7-yl)-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-(6,6-dimethyl-5,7-dihydropyrazolo[5,1-b][1,3]oxazin-3-yl)-oxo-λ6-sulfanylidene]-3-(3-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-[amino-[6-(methylamino)-5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-yl]-oxo-λ6-sulfanylidene]-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;N-[N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-S-(6-methoxy-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-yl)sulfonimidoyl]acetamide is sourced from PubChem (CID 158903291), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).